Sign In
Buy LMLLF
$0.0037
+0 (+0%)
At Close: Jun 22, 2026
PharmaDrug closes sale of German cannabis assets to Khiron Life Sciences
09:39am, Wednesday, 03'rd Aug 2022
PharmaDrug Inc said it is one step closer to streamlining its focus into a pure-play biotech company with the closing of the sale of its cannabis assets. The company said it has closed the previously
PharmaDrug announces non-brokered offering of $650,000 of convertible secured debentures and issuance of shares
09:29am, Tuesday, 02'nd Aug 2022
PharmaDrug Inc, which focuses on the research, development and commercialization of controlled substances and natural medicines such as psychedelics, revealed that it has raised $650,000 through the s
PharmaDrug unveils positive findings of study of cepharanthine (PD-001) candidate to treat esophageal cancer
08:37am, Thursday, 16'th Jun 2022
PharmaDrug Inc has released positive findings of a study of its cepharanthine (PD-001) candidate, which showed that when it is combined with chemotherapy drug paclitaxel, can treat esophageal cancer.
PharmaDrug Inc said it has agreed to sell its German medical cannabis distributing subsidiary Pharmadrug Production GmbH to Khiron Life Sciences Corp in exchange for 5,500,000 common shares of Khiron
PharmaDrug closes first tranche of a non-brokered private placement for aggregate gross proceeds of $280,000
06:05am, Monday, 30'th May 2022
PharmaDrug Inc has announced the closing of the first tranche of a non-brokered private placement which saw the company issue 7 million units at a price of $0.04 each for aggregate gross proceeds of $
PharmaDrug files provisional patent following positive findings for PD-001 and frontline chemotherapy combo in prostate cancer study
09:36am, Tuesday, 19'th Apr 2022
PharmaDrug Inc has revealed that its enteric coated oral formulation of cepharanthine (PD-001), when combined with cabazitaxel, significantly reduces tumor volume, and provides improved prostate can
PharmaDrug advances DMT-analogue glaucoma program with fabrication of medical device to lower intraocular pressure
09:27am, Thursday, 07'th Apr 2022
PharmaDrug Inc announced that, in collaboration with the Terasaki Institute for Biomedical Innovation (TIBI), it has successfully completed the fabrication of a novel medical device capable of delive
PharmaDrug advances PD-001, its improved version of cepharanthine to treat cancer and infectious disease
10:05am, Friday, 01'st Apr 2022
PharmaDrug Inc has provided an update on multiple activities currently underway which support its 'pipeline-in-a-pill' approach in the development of PD-001 -- its patented, orally bioavailable versi
PharmaDrug announces positive results from DMT-analogue program to treat glaucoma
09:10am, Wednesday, 23'rd Feb 2022
PharmaDrug Inc announced that it has successfully completed a head-to-head potency comparator study of its two undisclosed DMT-analogue candidates for the treatment of primary open-angle glaucoma (POA
PharmaDrug submits US provisional patent application for cepharanthine to treat prostate cancer
10:03am, Tuesday, 01'st Feb 2022
PharmaDrug Inc announced that it has filed a US provisional patent application which details the novel synergistic combination of cepharanthine (PD-001) ) and cabazitaxel on prostate cancer growth in
PharmaDrug initiates manufacturing of PD-001 for clinical programs in rare cancers and COVID-19
09:34am, Wednesday, 26'th Jan 2022
PharmaDrug Inc announced that it has initiated the manufacturing of PD-001, a patented enteric-coated oral formulation of cepharanthine, for non-clinical and clinical studies in cancer and infectious
PharmaDrug to Present at Wall Street Reporter's "Next Super Stock" Livestream Conference on Tuesday January 25, 2022
10:29am, Monday, 24'th Jan 2022
Toronto, Ontario--(Newsfile Corp. - January 24, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) (FSE: G111) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the develo
PharmaDrug appoints Cindy Hutnik to its scientific and clinical advisory board
08:59am, Monday, 13'th Dec 2021
PharmaDrug Inc has announced the appointment of Dr. Cindy Hutnik to the company's scientific and clinical advisory board. PharmaDrug said Hutnik will assist the company in its ongoing efforts to de
PharmaDrug aims to start clinical studies using cepharanthine for coronavirus in the second half of next year
11:17am, Tuesday, 30'th Nov 2021
PharmaDrug Inc has announced a boost for its cepharanthine candidate to treat coronavirus (COVID-19), saying the Type B pre-investigational new drug (IND) meeting with the US Food & Drug Administratio
PharmaDrug aimis to start clinical studies using cepharanthine for coronavirus in the second half of next year
10:56am, Tuesday, 30'th Nov 2021
PharmaDrug Inc has announced a boost for its cepharanthine candidate to treat coronavirus (COVID-19), saying the Type B pre-investigational new drug (IND) meeting with the US Food & Drug Administratio
